Literature DB >> 6170471

Poliovirus strain characterization: a WHO memorandum.

.   

Abstract

Reliable laboratory techniques for the intratypic characterization of poliovirus types 1, 2, and 3 isolates have an important role in the epidemiological surveillance of poliomyelitis and in studies of the safety and efficacy of poliovirus vaccines. Of the techniques available for poliovirus strain characterization, those potentially most useful are intratypic serodifferentiation and the biochemical techniques. The value of strain-specific (absorbed) antisera for antigenic characterization of strains has been clearly established for the identification of both vaccine-like viruses and different epidemic wild strains. Single-radial-diffusion techniques appear to be promising and should be further explored. Biochemical techniques involving studies of both virus polypeptides and nucleic acids are also capable of providing valuable information for strain characterization. Biological and physico-chemical tests are generally of limited value but their application may be useful in certain circumstances.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6170471      PMCID: PMC2395995     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  DIFFERENTIATION OF POLIOVIRUS TYPE 3 STRAINS BY CHROMATOGRAPHY ON ALUMINIUMHYDROXIDE.

Authors:  R THOMSSEN; M MAJER
Journal:  Arch Gesamte Virusforsch       Date:  1964-06-17

2.  A simple test for serodifferentiation of poliovirus strains within the same type.

Authors:  E WECKER
Journal:  Virology       Date:  1960-03       Impact factor: 3.616

3.  Antigenic analysis of polioviruses by kinetic studies of serum neutralization.

Authors:  W D McBRIDE
Journal:  Virology       Date:  1959-01       Impact factor: 3.616

4.  A physical property as a virus marker. Difference in avidity of cellulose resin for virulent (Mahoney) and attenuated (LSc, 2ab) strain of type 1 poliovirus.

Authors:  H L HODES; H D ZEPP; E AINBENDER
Journal:  Virology       Date:  1960-05       Impact factor: 3.616

5.  Parameters for differentiating vaccine-derived and wild poliovirus strains.

Authors:  J H Nakano; M H Hatch; M L Thieme; B Nottay
Journal:  Prog Med Virol       Date:  1978

6.  The use of a modified Wecker technique for the serodifferentiation of type 1 polioviruses related and unrelated to Sabin's vaccine strain. I. Standardization and evaluation of the test.

Authors:  J H NAKANO; H M GELFAND
Journal:  Am J Hyg       Date:  1962-05

7.  Improvement of methods for intratypic differentiation of polioviruses. II. Use of strain-specific antisera cross-adsorbed with antigens of heterologous strains in agar gel diffusion precipitation test for differentiation between wild and vaccine strains of poliovirus typess 1,2 and 3.

Authors:  S G Rubin; M P Chumakov; S S Savinskaya; Y V Pervikov; L A Gracheva; M K Voroshilova
Journal:  Arch Gesamte Virusforsch       Date:  1974

8.  Improvement of methods for intratypic differentiation of polioviruses. III. Neutralization test with cross-adsorbed sera for differentiation between wild and vaccine strains of polioviruses.

Authors:  Y V Pervikov; M P Chumakov; M K Voroshilova; S G Rubin; S S Savinskaya; L A Gracheva
Journal:  Arch Gesamte Virusforsch       Date:  1974

9.  Different pattern of elution of poliovirus strains from DEAE-cellulose and aluminium hydroxide gel.

Authors:  R Thomssen; M Majer
Journal:  Arch Gesamte Virusforsch       Date:  1965

10.  A sensitive, single-radial diffusion autoradiographic zone size enhancement technique for the assay of influenza haemagglutinin.

Authors:  J M Wood; G C Schild; R W Newman
Journal:  J Gen Virol       Date:  1980-04       Impact factor: 3.891

  10 in total
  1 in total

1.  Problems of live virus vaccine-associated poliomyelitis a paralytic case with isolation of all three poliovirus types.

Authors:  T Mertens; W Schürmann; J Kruppenbacher; K Rheingans; K Kellermann; G Maass; H J Eggers
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.